Stock SOBI SWEDISH ORPHAN BIOVITRUM AB
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Swedish Orphan Biovitrum AB

Equities

SOBI

SE0000872095

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-07-02 pm EDT 		5-day change 1st Jan Change
278.2 SEK -2.66% Intraday chart for Swedish Orphan Biovitrum AB -0.93% +4.19%
Jul. 02 Sweden's Sobi Begins Rolling Application for Gout Treatment in US MT
Jul. 02 Sobi Initiates Rolling Biologics License Application to FDA for SEL-212 for the Potential Treatment of Chronic Refractory Gout CI

Evolution of the average Target Price on Swedish Orphan Biovitrum AB

Price target over the last 5 years

History of analyst recommendation changes

71e37c7664df043590fbee.lfMORWFLuKen9VvhIn3J_DujDI4i00Ovs19M1OmQuSs.z8B5ICoj_-7ogmKyYAm4imnlSf5Hvi7ZhTcFsdDk7V7UkHl2AwLJws28aw~afe2e7c73468af956140005350cfaff9

Analyst Recommendations on Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum : Sobi publishes its Report for the Second Quarter 2015 - raises guidance GL
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
278.2 SEK
Average target price
329.6 SEK
Spread / Average Target
+18.48%
High Price Target
370 SEK
Spread / Highest target
+33.00%
Low Price Target
285 SEK
Spread / Lowest Target
+2.44%

Consensus detail

Consensus revision (last 18 months)

Ratings for Swedish Orphan Biovitrum AB

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SOBI Stock
  4. Consensus Swedish Orphan Biovitrum AB